ESPERION THERAPEUTICS INC (ESPR) Stock Analyst Earnings Estimates
NASDAQ:ESPR - Nasdaq - US29664W1053 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 78.4M -65.54% | 75.5M -3.70% | 116.334M 54.08% | 333.74M 186.88% | 408.69M 22.46% | 483.06M 18.20% | 852.36M 76.45% | 1.134B 33.04% | 1.14B 0.53% | 1.367B 19.91% | 473.28M -65.38% | 285.6M -39.66% | |
| EBITDA YoY % growth | -212.79M -76.08% | -179M 15.88% | -155.399M 13.18% | 49.974M 132.16% | 9.428M -81.13% | 40.136M 325.71% | 789.07M 1,865.99% | 1.499B 89.97% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -213.4M -75.78% | -179.5M 15.89% | -155.563M 13.34% | 45.95M 129.54% | 61.993M 34.91% | 41.3M -33.38% | 463.39M 1,022.01% | 655.35M 41.43% | 597.52M -8.82% | 757.45M 26.77% | 179.52M -76.30% | 122.2M -31.93% | |
| Operating Margin | -272.19% | -237.75% | -133.72% | 13.77% | 15.17% | 8.55% | 54.37% | 57.79% | 52.41% | 55.41% | 37.93% | 42.79% | |
| EPS YoY % growth | -9.56 -74.45% | -3.55 62.87% | -2.12 40.28% | -0.31 85.61% | 0.31 201.96% | 0.68 118.85% | 1.89 177.15% | 3.47 84.05% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 72.46% | -0.12 -136.00% | -0.09 72.18% | -0.01 93.20% | 0.48 448.15% | -0.12 | 0.03 133.33% | 0.05 600.00% | 0.09 -80.85% |
| Revenue Q2Q % growth | 62.786M 94.69% | 62.016M -54.97% | 70.074M -5.09% | 88.128M 70.68% | 188.19M 199.73% | 77.928M 25.66% | 83.742M 19.51% | 90.678M 2.89% | 98.94M -47.43% |
| EBITDA Q2Q % growth | -6.12M 85.50% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.076M 62.05% | -9.486M -113.13% | -3.366M -230.52% | 12.648M 178.92% | 110.98M 790.34% | 13.77M 245.16% | 19.278M 672.73% | 25.908M 104.84% | 33.762M -69.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.15 59.46% | -0.18 | 0.03 | 16.24% |
| Q2 2024 Q2Q % growth | -0.33 28.26% | -0.19 | -0.14 | -75.67% |
| Q1 2024 Q2Q % growth | 0.34 143.04% | 0.05 | 0.29 | 613.01% |
| Q4 2023 Q2Q % growth | -0.50 34.21% | -0.49 | -0.01 | -1.60% |
| Q3 2023 Q2Q % growth | -0.37 54.32% | -0.44 | 0.07 | 16.08% |
| Q2 2023 Q2Q % growth | -0.46 56.19% | -0.62 | 0.16 | 26.23% |
| Q1 2023 Q2Q % growth | -0.79 15.05% | -0.67 | -0.12 | -18.72% |
| Q4 2022 Q2Q % growth | -0.76 57.06% | -0.86 | 0.10 | 11.37% |
| Q3 2022 Q2Q % growth | -0.81 69.08% | -0.94 | 0.13 | 14.09% |
| Q2 2022 Q2Q % growth | -1.05 37.13% | -0.94 | -0.11 | -11.17% |
| Q1 2022 Q2Q % growth | -0.93 73.43% | -1.06 | 0.13 | 12.63% |
| Q4 2021 Q2Q % growth | -1.77 54.50% | -2.32 | 0.55 | 23.55% |
| Q3 2021 Q2Q % growth | -2.62 14.66% | -2.86 | 0.24 | 8.41% |
| Q2 2021 Q2Q % growth | -1.67 -138.66% | -1.88 | 0.21 | 11.15% |
| Q1 2021 Q2Q % growth | -3.50 -23.24% | -2.57 | -0.93 | -36.35% |
| Q4 2020 Q2Q % growth | -3.89 -72.12% | -3.84 | -0.05 | -1.43% |
| Q3 2020 Q2Q % growth | -3.07 -21.83% | -3.50 | 0.43 | 12.41% |
| Q2 2020 Q2Q % growth | 4.32 314.93% | 1.74 | 2.58 | 148.23% |
| Q1 2020 Q2Q % growth | -2.84 -192.51% | -3.36 | 0.52 | 15.51% |
| Q4 2019 Q2Q % growth | -2.26 | -2.72 | 0.46 | 17.00% |
| Q3 2019 Q2Q % growth | -2.52 | -1.99 | -0.53 | -26.73% |
| Q2 2019 Q2Q % growth | -2.01 | -1.90 | -0.11 | -6.05% |
| Q1 2019 Q2Q % growth | 3.07 | 0.75 | 2.32 | 309.12% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 51.632M 52.00% | 52.348M | -716K | -1.37% |
| Q2 2024 Q2Q % growth | 73.834M 186.33% | 48.443M | 25.391M | 52.41% |
| Q1 2024 Q2Q % growth | 137.735M 466.14% | 85.373M | 52.362M | 61.33% |
| Q4 2023 Q2Q % growth | 32.25M 71.54% | 29.271M | 2.979M | 10.18% |
| Q3 2023 Q2Q % growth | 33.969M 78.78% | 30.175M | 3.794M | 12.57% |
| Q2 2023 Q2Q % growth | 25.786M 37.16% | 25.13M | 656K | 2.61% |
| Q1 2023 Q2Q % growth | 24.329M 29.41% | 22.452M | 1.877M | 8.36% |
| Q4 2022 Q2Q % growth | 18.8M 22.08% | 21.264M | -2.464M | -11.59% |
| Q3 2022 Q2Q % growth | 19M 31.94% | 20.313M | -1.313M | -6.46% |
| Q2 2022 Q2Q % growth | 18.8M -53.81% | 19.083M | -283K | -1.48% |
| Q1 2022 Q2Q % growth | 18.8M 135.00% | 15.695M | 3.105M | 19.78% |
| Q4 2021 Q2Q % growth | 15.4M 60.42% | 14.771M | 629K | 4.26% |
| Q3 2021 Q2Q % growth | 14.4M 278.95% | 12.126M | 2.274M | 18.75% |
| Q2 2021 Q2Q % growth | 40.7M -80.82% | 43.028M | -2.328M | -5.41% |
| Q1 2021 Q2Q % growth | 8M 344.44% | 22.475M | -14.475M | -64.40% |
| Q4 2020 Q2Q % growth | 9.6M 860.00% | 12.766M | -3.166M | -24.80% |
| Q3 2020 Q2Q % growth | 3.8M 280.00% | 5.273M | -1.473M | -27.93% |
| Q2 2020 Q2Q % growth | 212.2M 21,120.00% | 150.93M | 61.27M | 40.59% |
| Q1 2020 Q2Q % growth | 1.8M -98.76% | 528.87K | 1.271M | 240.35% |
| Q4 2019 Q2Q % growth | 1M | 909.636K | 90.364K | 9.93% |
| Q3 2019 Q2Q % growth | 1M | 918K | 82K | 8.93% |
| Q2 2019 Q2Q % growth | 1M | 951.997K | 48.003K | 5.04% |
| Q1 2019 Q2Q % growth | 145.4M | 60.308M | 85.092M | 141.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.31% | 0% | -63.29% |
| Revenue | 0% | -11.81% | -0.01% | -6.06% |